These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

708 related articles for article (PubMed ID: 34416319)

  • 21. Cardiac Complications Associated with COVID-19, MIS-C, and mRNA COVID-19 Vaccination.
    Chin SE; Bhavsar SM; Corson A; Ghersin ZJ; Kim HS
    Pediatr Cardiol; 2022 Mar; 43(3):483-488. PubMed ID: 35258639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Peripheral Immune Landscape in a Patient with Myocarditis after the Administration of BNT162b2 mRNA Vaccine.
    Yoon BK; Oh TG; Bu S; Seo KJ; Kwon SH; Lee JY; Kim Y; Kim JW; Ahn HS; Fang S
    Mol Cells; 2022 Oct; 45(10):738-748. PubMed ID: 35904026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronavirus disease (COVID-19) associated delayed-onset fulminant myocarditis in patient with a history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
    Ishikura H; Maruyama J; Hoshino K; Matsuoka Y; Yano M; Arimura T; Katano H; Kato S; Kitamura T; Nakamura Y
    J Infect Chemother; 2021 Dec; 27(12):1760-1764. PubMed ID: 34446351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic lupus erythematosus myocarditis after COVID-19 vaccination.
    Sogbe M; Blanco-Di Matteo A; Di Frisco IM; Bastidas JF; Salterain N; Gavira JJ
    Reumatol Clin (Engl Ed); 2023 Feb; 19(2):114-116. PubMed ID: 36739118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STEMI Mimic: Focal Myocarditis in an Adolescent Patient After mRNA COVID-19 Vaccine.
    Azir M; Inman B; Webb J; Tannenbaum L
    J Emerg Med; 2021 Dec; 61(6):e129-e132. PubMed ID: 34756746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe COVID-19-associated myocarditis with cardiogenic shock - management with assist devices - a case report & review.
    Noone S; Flinspach AN; Fichtlscherer S; Zacharowski K; Sonntagbauer M; Raimann FJ
    BMC Anesthesiol; 2022 Dec; 22(1):385. PubMed ID: 36503438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection against MIS-C outweighs the risk of myocarditis after Covid-19 vaccination in children.
    Mariani M; Caorsi R; Consolaro A; Brisca G; Sticchi C; Gattorno M; Castagnola E; Ravelli A
    Ital J Pediatr; 2022 Aug; 48(1):142. PubMed ID: 35927681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age.
    Das BB; Kohli U; Ramachandran P; Nguyen HH; Greil G; Hussain T; Tandon A; Kane C; Avula S; Duru C; Hede S; Sharma K; Chowdhury D; Patel S; Mercer C; Chaudhuri NR; Patel B; Ang JY; Asmar B; Sanchez J; Khan D
    J Pediatr; 2021 Nov; 238():26-32.e1. PubMed ID: 34339728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children.
    Dionne A; Sperotto F; Chamberlain S; Baker AL; Powell AJ; Prakash A; Castellanos DA; Saleeb SF; de Ferranti SD; Newburger JW; Friedman KG
    JAMA Cardiol; 2021 Dec; 6(12):1446-1450. PubMed ID: 34374740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Case of Myocarditis Presenting With a Hyperechoic Nodule After the First Dose of COVID-19 mRNA Vaccine.
    Park S; You J
    J Korean Med Sci; 2022 Apr; 37(16):e131. PubMed ID: 35470603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocarditis After BNT162b2 and mRNA-1273 Vaccination.
    Larson KF; Ammirati E; Adler ED; Cooper LT; Hong KN; Saponara G; Couri D; Cereda A; Procopio A; Cavalotti C; Oliva F; Sanna T; Ciconte VA; Onyango G; Holmes DR; Borgeson DD
    Circulation; 2021 Aug; 144(6):506-508. PubMed ID: 34133884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular safety of COVID-19 vaccines in real-world studies: a systematic review and meta-analysis.
    Chang Y; Lv G; Liu C; Huang E; Luo B
    Expert Rev Vaccines; 2023; 22(1):25-34. PubMed ID: 36413786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multisystem inflammatory syndrome in children after BNT162b2 messenger RNA SARS-CoV-2 vaccination.
    Sakaida K; Iwashima S; Katsuki J; Sato K; Miyairi I
    Pediatr Int; 2023 Jan; 65(1):e15441. PubMed ID: 36513963
    [No Abstract]   [Full Text] [Related]  

  • 34. Successful heart transplantation for COVID-19-associated post-infectious fulminant myocarditis.
    Gaudriot B; Mansour A; Thibault V; Lederlin M; Cauchois A; Lelong B; Ross JT; Leurent G; Tadié JM; Revest M; Verhoye JP; Flecher E; Nesseler N
    ESC Heart Fail; 2021 Aug; 8(4):2625-2630. PubMed ID: 33934560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics and prognostic factors of myocarditis associated with the mRNA COVID-19 vaccine.
    Woo W; Kim AY; Yon DK; Lee SW; Hwang J; Jacob L; Koyanagi A; Kim MS; Moon DH; Jung JW; Choi JY; Jung SY; Eun LY; Lee S; Shin JI; Smith L
    J Med Virol; 2022 Apr; 94(4):1566-1580. PubMed ID: 34862617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myocarditis Following COVID-19 Vaccination: A Systematic Review (October 2020-October 2021).
    Lee ASY; Balakrishnan IDD; Khoo CY; Ng CT; Loh JKX; Chan LL; Teo LLY; Sim DKL
    Heart Lung Circ; 2022 Jun; 31(6):757-765. PubMed ID: 35227610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocarditis Following a COVID-19 Messenger RNA Vaccination: A Japanese Case Series.
    Murakami Y; Shinohara M; Oka Y; Wada R; Noike R; Ohara H; Fujino T; Ikeda T
    Intern Med; 2022 Feb; 61(4):501-505. PubMed ID: 34840235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.
    Pillay J; Gaudet L; Wingert A; Bialy L; Mackie AS; Paterson DI; Hartling L
    BMJ; 2022 Jul; 378():e069445. PubMed ID: 35830976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
    Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC
    JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review.
    Lui DTW; Lee KK; Lee CH; Lee ACH; Hung IFN; Tan KCB
    Front Public Health; 2021; 9():778964. PubMed ID: 34888290
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.